Study shows patients given Acetadote versus placebo have a higher transplant-free survival rate and are less likely to require liver transplant NASHVILLE, Tenn., March 30, 2010 /PRNewswire via COMTEX ...
Credit: Getty Images. The newly approved regimen is expected to simplify administration and potentially reduce medication errors and dose-related reactions. Certain factors should be considered when ...
NASHVILLE, Tenn., March 22, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced that it has completed the U.S. launch of its new formulation of Acetadote® ...
ALLEGAN -- Perrigo Co. (Nasdaq: PRGO) Monday announced that it has made initial shipments distributing Cumberland Pharmaceuticals Inc.'s authorized generic form of Acetadote (acetylcysteine) injection ...
Cumberland Pharmaceuticals announced that it has made available its new formulation of Acetadote (acetylcysteine injection). The new formulation is free of preservatives, ethylene diamine tetracetic ...
ALLEGAN -- The generic drug and over-the-counter health product manufacturer Perrigo Co. (Nasdaq: PRGO) announced that it has agreed to settle its Hatch-Waxman litigation relating to Acetadote ...
NASHVILLE, Tenn., Dec. 9, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on delivering high-quality products to improve patient care, ...
ALLEGAN, MI-- Perrigo Co. will be able to market a generic form of acetaminophen overdose treatment Acetadote now that it has settled a legal action brought by Cumberland Pharmaceuticals Inc.
Perrigo announced that it has made initial shipments distributing Cumberland Pharmaceuticals's Authorized Generic form of Acetadote injection. The Authorized Generic is free of EDTA and any other ...
- Recall is a precautionary measure not based on any adverse events NASHVILLE, Tenn., Dec. 30, 2010 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced today that it has ...
NASHVILLE, Tenn., March 30 Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) has submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) for the use of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results